Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 21 studies | 26% ± 10% | |
naive B cell | 12 studies | 22% ± 6% | |
memory B cell | 11 studies | 22% ± 4% | |
precursor B cell | 5 studies | 43% ± 12% | |
epithelial cell | 5 studies | 22% ± 5% | |
immature B cell | 4 studies | 32% ± 10% | |
astrocyte | 4 studies | 22% ± 4% | |
endothelial cell | 3 studies | 21% ± 3% | |
pro-B cell | 3 studies | 49% ± 7% | |
germinal center B cell | 3 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 28% ± 3% | |
glutamatergic neuron | 3 studies | 31% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 4% | |
oligodendrocyte | 3 studies | 20% ± 3% | |
abnormal cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 942.01 | 1445 / 1445 | 100% | 13.64 | 183 / 183 |
lung | 100% | 807.64 | 578 / 578 | 100% | 17.98 | 1155 / 1155 |
breast | 100% | 1054.43 | 459 / 459 | 100% | 18.37 | 1117 / 1118 |
brain | 100% | 815.77 | 2639 / 2642 | 100% | 18.40 | 705 / 705 |
intestine | 100% | 1312.14 | 966 / 966 | 100% | 18.66 | 526 / 527 |
thymus | 100% | 1216.55 | 653 / 653 | 100% | 14.11 | 603 / 605 |
stomach | 100% | 976.99 | 359 / 359 | 100% | 17.49 | 285 / 286 |
bladder | 100% | 990.19 | 21 / 21 | 100% | 13.58 | 502 / 504 |
ovary | 100% | 936.87 | 180 / 180 | 100% | 11.44 | 428 / 430 |
uterus | 100% | 977.26 | 170 / 170 | 99% | 13.41 | 456 / 459 |
kidney | 100% | 1130.75 | 89 / 89 | 99% | 11.98 | 894 / 901 |
pancreas | 100% | 627.76 | 328 / 328 | 99% | 11.07 | 176 / 178 |
liver | 100% | 729.44 | 226 / 226 | 99% | 8.61 | 401 / 406 |
prostate | 100% | 925.82 | 245 / 245 | 99% | 10.32 | 495 / 502 |
adrenal gland | 100% | 1068.86 | 258 / 258 | 97% | 9.83 | 224 / 230 |
skin | 100% | 1052.71 | 1808 / 1809 | 97% | 11.36 | 457 / 472 |
adipose | 100% | 953.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.94 | 29 / 29 |
muscle | 100% | 2024.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1780.03 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.54 | 1 / 1 |
blood vessel | 100% | 755.72 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1134.60 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 7.63 | 70 / 80 |
peripheral blood | 86% | 810.52 | 802 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070681 | Biological process | glutaminyl-tRNAGln biosynthesis via transamidation |
GO_0031647 | Biological process | regulation of protein stability |
GO_0032543 | Biological process | mitochondrial translation |
GO_0030956 | Cellular component | glutamyl-tRNA(Gln) amidotransferase complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0050567 | Molecular function | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | QRSL1 |
Protein name | Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7) (Glutaminyl-tRNA synthase-like protein 1) Glutaminyl-tRNA amidotransferase subunit QRSL1 |
Synonyms | |
Description | FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). . FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). . |
Accessions | B2RBJ8 Q9H0R6 X6R772 ENST00000369046.8 [Q9H0R6-1] ENST00000369044.1 |